Renal Cell Cancer Update

Dr Alan Bryce from the Mayo Clinic in Phoenix, Arizona, discusses current practice patterns and recent advances in the management of metastatic castration-resistant prostate cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodaymCRPC21/Issue1).

Dr Arvind Dasari from the University of Texas MD Anderson Cancer Center discusses recent advances and future directions for the management of early-stage and advanced colorectal cancers. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayCRCAnal21/Issue1).

Dr Bradley Monk from the University of Arizona College of Medicine in Phoenix discusses the management of advanced ovarian cancers. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayOvarian21).

Dr Gregory Riely from the Memorial Sloan Kettering Cancer Center in New York City discusses recent advances and future directions in the management of patients with NSCLC and EGFR exon 20 insertion mutations. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayNSCLCEGFR21).

Dr Adil Daud from the UCSF Helen Diller Family Comprehensive Cancer Center discusses recent advances and future directions in the use of immunotherapy for the management of wild-type and BRAF-mutant melanoma. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayMelanomaImmuno21).

Dr Andrew Evens from the Rutgers Cancer Institute in New Jersey discusses the management of newly diagnosed and advanced Hodgkin lymphoma in younger and older patients. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHL21).

Dr Matthew Powell from the Washington University School of Medicine in St Louis, Missouri, discusses therapeutic advances and novel investigational strategies for the management of endometrial cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayEndometrial21).

Dr Arnon Kater from the Amsterdam University Medical Centers in Amsterdam discusses recent advances in the management of chronic lymphocytic leukemia. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayCLL21/Issue1).

Dr Michael Savona from Vanderbilt University School of Medicine in Nashville, Tennessee, discusses recent advances and future directions in the management of myelodysplastic syndromes. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayMDS21/Issue2).

Dr Jonathon Cohen from the Winship Cancer Institute of Emory University in Atlanta discusses recent advances and future directions in the use of CAR T-cell therapy for the management of non-Hodgkin lymphoma. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayCARTLymphoma21).

Dr Cristina Rodriguez from the Fred Hutchinson Cancer Research Center in Seattle discusses the current management of head and neck cancers. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHeadNeck21).

Dr Ruben Mesa from the Mays Cancer Center in San Antonio, Texas, discusses the pathogenesis and management of myeloproliferative neoplasms. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayMPN21).

Dr Michael Mauro from the Memorial Sloan Kettering Cancer Center in New York City, New York, discusses the management of chronic myeloid leukemia. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayCML21).

Dr Sumanta Pal from the City of Hope Comprehensive Cancer Center in Duarte, California discusses the management of advanced renal cell carcinoma. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayRCC21).

Dr Marcia Brose from the Sidney Kimmel Cancer Center in Philadelphia discusses the latest clinical data on targeted therapeutic approaches for the management of advanced thyroid cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayThyroid21/Issue2).

Dr Samuel Klempner from Massachusetts General Hospital in Boston, Massachusetts discusses recent updates on immunotherapy and targeted therapy for gastroesophageal cancers. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayGEJ21/Issue2).

Dr Ian Krop from the Dana-Farber Cancer Institute in Boston discusses recently published and emerging research on the treatment of HER2-low breast cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHER2LowBC21).

Dr Kathleen Moore from the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma, discusses key presentations on gynecologic cancers from the 2021 ASCO Annual Meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASCOGyn21).

Dr Lori Wirth from the Massachusetts General Hospital in Boston discusses the latest clinical data and ongoing investigations on targeted therapeutic approaches for the management of RET-altered and NTRK fusion-positive thyroid cancers. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayThyroid21/Issue1).

Dr Joel Neal from Stanford University in Stanford, California, discusses key presentations on lung cancer from the 2021 ASCO Annual Meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASCOLung21).